**Specifications table**TableSubject area*Chemistry, biology*More specific subject area*Biomaterials*Type of data*Tables, figures*How data was acquired*Static compression and tensile mechanical testing (Instron 5655), Dynamic mechanical compression (ElectroForce Biodynamic® Test Instrument 5160), Mercury intrusion porosimeter (PoreMaster 60GT Quantachrome), Immunohistochemistry, Element detection (EDX, EDAX Inc.)*Data format*Analyzed*Experimental factors*Compression and tensile mechanical properties in static mode were evaluated with Instron; dynamic compression testing with an ElectroForce bioreactor. The hierarchical porous structure of the scaffolds was analyzed via mercury intrusion porosimeter. Chondrogenic differentiation was studied via Hematoxylin and Eosin, Alcian Blue and Collagen II staining; osteogenic differentiation was studied via Hematoxylin and Eosin, Alizarin Red and Collagen I staining. Energy-dispersive X-ray analysis (EDX) was carried out for elemental mapping analysis.*Experimental features*Physico-mechanical characterization, histology and immunohistochemistry*Data source location*N/A*Data accessibility*Within this article*

**Value of the data**•Data presented here provides optimized conditions for the assessment of mesenchymal stem cell differentiation on stiffness softening scaffolds.•Compression mechanical testing along with histological assessment was sensitive to elucidating how stiffness softening affects stem cell differentiation.

1. Data {#s0005}
=======

[Fig. 1](#f0005){ref-type="fig"} depicts cell expansion and differentiation of human bone-marrow derived mesenchymal stem cells (hBM-MSCs) on 3D-TIPS PUU-POSS scaffolds exhibiting stiffness softening. [Table 1](#t0005){ref-type="table"} shows the effect of the infill density (i.e. 3D priting) and the variou 3D-TIPS thermal conditions (i.e. CC, CC + H and RTC + H) on the mechanical properties of the scaffolds. [Table 2](#t0010){ref-type="table"} demonstrates the isothermal stiffness softening behaviour of 50% infill density scaffolds after a 28-day period incubation *in vitro* at body temperature (37°C), with all scaffold groups reaching their intrinsic elasticity (i.e. ׳stiffness memory׳ concept). [Table 3](#t0015){ref-type="table"} shows viscoelastic behaviours of 50% infill density scaffolds during dynamic compression testing, all reaching their intrinsic elasticity. [Fig. 2](#f0010){ref-type="fig"} and [Table 4](#t0020){ref-type="table"} demonstrate the hierarchical micro-/nano- porous structure of the various scaffold groups. [Figs. 3](#f0015){ref-type="fig"} and [5](#f0025){ref-type="fig"} show histological sectioning demonstrating chondrogenic and osteogenic differentiation, respectively, on the various scaffolds. [Fig. 4](#f0020){ref-type="fig"} and [Tables 5](#t0025){ref-type="table"} and [6](#t0030){ref-type="table"} show elemental mapping analysis after chondrogenic and osteogenic differentiation on the various scaffolds.Fig. 1Schematics of hBM-MSCs culture, expansion, seeding and differentiation towards the chondrogenic and osteogenic lineages.Fig. 1Table 1Physical, tensile and compression mechanical properties of 3D-TIPS PUU-POSS scaffolds with various infill densities.Table 1**ScaffoldInfill density, %Scaffold density, d**~**a**~**, kg/m**^**−3**^**Total porosity, 100%Compression strength, MPaCompression modulus, MPaCC**8044 ± 396.2 ± 0.30.54 ± 0.020.82 ± 0.03**CC**7040 ± 396.5 ± 0.30.48 ± 0.010.75 ± 0.01**CC**6037 ± 596.8 ± 0.40.34 ± 0.010.63 ± 0.02**CC**5036 ± 496.9 ± 0.40.33 ± 0.030.48 ± 0.08**CC**4030 ± 697.4 ± 0.50.17 ± 0.040.39 ± 0.03**CC**3027 ± 397.7 ± 0.30.10 ± 0.020.25 ± 0.02**CC+H**8056 ± 895.1 ± 0.70.38 ± 0.010.56 ± 0.01**CC+H**7051 ± 495.5 ± 0.30.34 ± 0.040.41 ± 0.02**CC+H**6049 ± 395.8 ± 0.30.26 ± 0.020.37 ± 0.03**CC+H**5045 ± 596.1 ± 0.50.21 ± 0.010.27 ± 0.03**CC+H**4041 ± 496.5 ± 0.30.11 ± 0.010.20 ± 0.02**CC+H**3037 ± 296.8 ± 0.20.13 ± 0.010.12 ± 0.01**RTC+H**8048 ± 1095.8 ± 0.80.35 ± 0.010.28 ± 0.01**RTC+H**7043 ± 496.2 ± 0.40.25 ± 0.020.26 ± 0.02**RTC+H**6039 ± 596.6 ± 0.40.22 ± 0.010.22 ± 0.01**RTC+H**5038 ± 396.7 ± 0.30.17 ± 0.020.15 ± 0.03**RTC+H**4033 ± 597.1 ± 0.40.12 ± 0.010.13 ± 0.01**RTC+H**3029 ± 397.5 ± 0.30.10 ± 0.010.10 ± 0.01Table 2Physical and mechanical properties of 3D-TIPS PUU-POSS scaffolds (50% infill density) before and after incubation at body temperature (37°C) for 28 days.Table 2**3D-TIPS scaffold, 50% infillScaffold density, kg/m**^**3**^**Total porosity, 100%Young׳s modulus, MPa (Tensile)Ultimate tensile strength, MPa (Tensile)Ultimate tensile strain, % (Tensile)Toughness, J m**^**−3**^** × 10**^**4**^**(Tensile)Compression strength\@25%, MPaCompression modulus\@25%, MPa50CC**Day 036 ± 496.9 ± 0.40.98 ± 0.141.33 ± 0.09179 ± 8137 ± 220.33 ± 0.020.51 ± 0.08Day 2829 ± 497.4 ± 0.30.45 ± 0.080.77 ± 0.15230 ± 13115 ± 200.18 ± 0.030.16 ± 0.01**50CC+H**Day 045 ± 596.1 ± 0.50.53 ± 0.020.76 ± 0.05236 ± 19113 ± 270.22 ± 0.040.27 ± 0.03Day 2839 ± 596.7 ± 0.40.39 ± 0.090.72 ± 0.12240 ± 18110 ± 140.17 ± 0.020.13 ± 0.01**50RTC+H**Day 038 ± 396.7 ± 0.30.44 ± 0.060.67 ± 0.03146 ± 15146 ± 120.17 ± 0.050.15 ± 0.01Day 2832 ± 397.2 ± 0.30.42 ± 0.080.65 ± 0.06149 ± 19146 ± 200.17 ± 0.020.12 ± 0.01Table 3Hysteresis values (i.e. energy loss) of the various scaffolds (50% infill density) during tensile and compression cyclic loading at day 0 and after incubation for 28 days at 37°C.Table 3**Type of testDayHysteresis energy (J/m**^**3**^**)50CC50CC+H50RTC+HTensileD0**0--200 cycles160 ± 1121 ± 815 ± 71000--1200 cycles133 ± 118 ± 213 ± 210,000--10,200 cycles24 ± 814 ± 313 ± 4200,000--200,100 cycles15 ± 58 ± 311 ± 4**D28**0--200 cycles31 ± 617 ± 412 ± 41000--1200 cycles17 ± 613 ± 510 ± 210,000--10,200 cycles12 ± 510 ± 49 ± 3200,000--200,200 cycles10 ± 410 ± 49 ± 3**CompressionD0**0--200 cycles274 ± 7125 ± 1012 ± 41000--1200 cycles124 ± 991 ± 1014 ± 410,000--10,200 cycles101 ± 1081 ± 413 ± 4100,000--100,200 cycles90 ± 880 ± 412 ± 4200,000--200,100 cycles60 ± 552 ± 310 ± 4**D28**0--200 cycles63 ± 556 ± 88 ± 31000--1200 cycles43 ± 535 ± 910 ± 510,000--10,200 cycles31 ± 523 ± 710 ± 4100,000--100,200 cycles13 ± 515 ± 48 ± 4200,000--200,100 cycles10 ± 49 ± 48 ± 3Fig. 2Porosity analysis of 50% infill density scaffolds. Mercury porosimeter measurements in terms of pore size and pore size distribution [@bib2].Fig. 2Table 4Pore size and pore size distribution of 50% infill density scaffolds [@bib2].Table 4**ScaffoldPore diameter, nmPore volume, cm**^**3**^**/gRelative pore volume, %Surface area, m**^**2**^**/gRelative surface area, %50CC**456,882--100029.7558.461.552.651000--10011.2522.1048.6783.16100--39.8919.448.3014.19**Total**50.8910058.52100**50CC+H**439,998--100031.3175.751.4761000--1006.5715.8918.8276.84100--33.458.364.217.16**Total**41.3310024.49100**50RTC+H**387,810--100048.6495.162.6858.511000--1000000100--32.474.841.941.49**Total**51.111004.58100Fig. 3Chondrogenic differentiation on 50% infill density scaffolds. (A-I) Histological analysis of chondrogenic differentiation at week 4: in cross-section for (A, D, G) 50CC, (B, E, H) 50CC+H, and (C, F, I) 50RTC+H. Stained with Hematoxylin and Eosin (H&E), Alcian Blue (A-Blue) and Collagen II (COL2). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article).Fig. 3Fig. 4SEM and EDX imaging of hBM-MSCs cultured on the various 50% infill density scaffolds under chondrogenic and osteogenic conditions: (A) after 28 days chondrogenesis on 50CC, 50CC+H and 50RTC+H scaffolds; (B) after 21 days osteogenesis on 50CC, 50CC+H and 50RTC+H scaffolds; (C) human femoral head cartilage control; (D) human femoral head bone control. Scale bar 100 μm.Fig. 4Fig. 5Osteogenic differentiation on 50% infill density scaffolds. (A-I) Histological analysis of osteogenic differentiation at week 4: in cross-section for (A, D, G) 50CC, (B, E, H) 50CC+H, and (C, F, I) 50RTC+H. Stained with H&E, Alizarin red and Collagen I (COL1). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article).Fig. 5Table 5EDX element analysis of scaffolds (50% infill density) after day 28 chondrogenesis. (weight %, wt%; atomic concentration%, at%)Table 5**ElementHFH-CHFH-C50CC50CC+H50RTC+Hwt%at%wt%at%wt%at%wt%at%C**65.6479.7669.583.5568.7380.0170.5183.55**O**17.6016.0118.4214.720.4217.9216.4214.70**Na**2.371.500.660.411.741.060.660.41**Si**1.371.190.610.360.370.190.710.36**P**0.670.310.360.120.670.180.260.12**Ca**0.920.380.280.030.920.050.080.03**Au**11.430.848.360.8311.430.5811.350.83**Total**100%100%100%100%100%100%100%100%[^2]Table 6EDX element analysis of the scaffolds (50% infill density) after 21 days osteogenesis. (weight, wt%; atomic concentration%, at%)Table 6**ElementHFH-BHFH-B50CC50CC+H50RTC+Hwt%at%wt%at%wt%at%wt%at%C**77.6288.9983.6391.4461.2773.3469.2384.03**O**8.217.067.115.8622.6721.1215.5514.17**Na**0.710.420.650.373.492.270.630.40**Si**1.430.700.240.112.381.860.330.17**P**0.830.371.270.540.360.170.220.10**Ca**3.721.932.660.881.480.610.290.11**Au**7.480.524.450.308.350.6313.741.02**Total**100%100%100%100%100%100%100%100%[^3]

1.1. Cell expansion and differentiation of hBM-MSCs on 3D-TIPS PUU-POSS scaffolds {#s0010}
---------------------------------------------------------------------------------

See [Fig. 1](#f0005){ref-type="fig"}.

1.2. Physico-mechanical characterization and ׳stiffness memory׳ of 3D-TIPS PUU-POSS scaffolds {#s0015}
---------------------------------------------------------------------------------------------

See [Table 1](#t0005){ref-type="table"}, [Table 2](#t0010){ref-type="table"}, [Table 3](#t0015){ref-type="table"}, [Table 4](#t0020){ref-type="table"} and [Fig. 2](#f0010){ref-type="fig"}.

1.3. Chondrogenic and osteogenic evaluation {#s0020}
-------------------------------------------

See [Fig. 3](#f0015){ref-type="fig"}, [Fig. 4](#f0020){ref-type="fig"}, [Fig. 5](#f0025){ref-type="fig"} and [Tables 5](#t0025){ref-type="table"} and [6](#t0030){ref-type="table"}.

2. Experimental design, materials and methods {#s0025}
=============================================

2.1. 3D-TIPS PUU-POSS scaffold manufacturing {#s0033}
--------------------------------------------

3D-TIPS PUU-POSS scaffolds at different thermal conditions (Cyo-coagulation, CC; cryo-coagulation and heating, CC + H; and room temperature coagulation and heating, RTC + H) were manufactured by a 3D confined thermal induced phase separation process (3D-TIPS) based on self-assembly, phase transition and phase separation of the polymeric solution at controlled temperatures as described in [@bib1], [@bib2].

2.2. Cell expansion and differentiation {#s0030}
---------------------------------------

A human bone marrow derived mesenchymal stem cell line was expanded, seeded and differentiated ([Table S1](#s0036)-[S2](#s0036)) on 3D-TIPS PUU-POSS scaffolds with stiffness softening as described in [@bib1].

2.3. Physico-mechanical characterization of the scaffolds prior to cell seeding {#s0035}
-------------------------------------------------------------------------------

Static mechanical testing of the scaffolds under tensile and compression mode, for different infill densities, before and after incubation over 28 days at body temperature *in vitr*o (37°C), was performed with an Instron 5655 tester as described previously [@bib1].

A mercury intrusion porosimeter (PoreMaster 60GT, Quantachrome, UK) was used to characterise the pore structure including the pore size, pore volume, size distribution and surface area of freeze-dried scaffolds (50% infill density).

2.4. Chondrogenic and osteogenic assessment {#s0040}
-------------------------------------------

Element detection on cell-laden 50% infill density scaffolds after differentiation was quantified via Energy-dispersive X-ray (EDX) analysis as described in [@bib1].

Histological section and staining of the scaffolds (50% infill density) was performed after chondrogenic and osteogenic differentiation as previously described [@bib1].

Transparency document. Supplementary material {#s0031}
=============================================

Supplementary material

Appendix A. Supplementary material {#s0041}
==================================

Supplementary material
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[^1]: Current address: Bio-Active Materials Group, School of Materials, The University of Manchester, Manchester, United Kingdom.

[^2]: HFH-C, human femoral head cartilage.

[^3]: HFH-B, human femoral head bone.
